Treatment Adherence and Compliance
"Treatment Adherence and Compliance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Extent to which the patient follows prescribed treatment such as keeping APPOINTMENTS AND SCHEDULES and MEDICATION ADHERENCE for desired therapeutic outcome. It implies active responsibility shared by patient and health care providers.
| Descriptor ID |
D000074822
|
| MeSH Number(s) |
F01.100.150.750 F01.145.488.887 N05.300.150.800
|
| Concept/Terms |
Treatment Adherence- Treatment Adherence
- Adherence, Treatment
- Therapeutic Adherence
- Adherence, Therapeutic
|
Below are MeSH descriptors whose meaning is more general than "Treatment Adherence and Compliance".
Below are MeSH descriptors whose meaning is more specific than "Treatment Adherence and Compliance".
This graph shows the total number of publications written about "Treatment Adherence and Compliance" by people in this website by year, and whether "Treatment Adherence and Compliance" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2019 | 2 | 2 | 4 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Treatment Adherence and Compliance" by people in Profiles.
-
Managing hypertension in rural Uganda: Realities and strategies 10 years of experience at a district hospital chronic disease clinic. PLoS One. 2020; 15(6):e0234049.
-
Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial. JAMA Netw Open. 2019 11 01; 2(11):e1914729.
-
Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial. Oral Oncol. 2019 10; 97:82-91.
-
A Clinical Informatics Approach to Reengagement in HIV Care in the Emergency Department. J Public Health Manag Pract. 2019 May/Jun; 25(3):270-273.
-
Characteristics at the time of oxygen initiation associated with its adherence: Findings from the COPD Long-term Oxygen Treatment Trial. Respir Med. 2019 03; 149:52-58.